Ji Young Kim

Ji Young Kim

Auto-generated profile, based on publicly available information

Ji Young Kim

Department of Breast Surgery, School of Medicine, Ajou University, Suwon, Korea

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 January 2023 in BMC Women's Health
Verified
Journal Article
Open access
PDF file
JPJin-Hee Park
Jin-Hee Park
YJYong Sik Jung
Yong Sik Jung
JKJi Young Kim
Ji Young Kim
SBSUN HYOUNG BAE
SUN HYOUNG BAE
Background: Although quality of life (QOL) improves over time for most breast cancer patients after their treatment, some patients may show different patterns of QOL. Beyond determining distinct QOL trajectories, identifying characteristics of patients who have different trajectories can help identify breast cancer patients who may benefit from intervention. We aimed to identify trajectories of QOL in breast cancer patients for one year after the end of primary treatment, to determine the factors influencing these changes. Methods: This longitudinal study recruited 140 breast cancer patients. Patients' QOL, symptom experience, self-efficacy, and social support were assessed using the Functional Assessment of Cancer Therapy Scale-G, Memorial Symptom Assessment Scale-Short Form, Self-Efficacy Scale for Self-Management of Breast Cancer, and Interpersonal Support Evaluation List-12. Data were collected immediately after the end of primary treatment (T1) and at three (T2), six (T3), and 12 months (T4) after primary treatment. Group-based trajectory modeling was used to identify distinct subgroups of patients with similar patterns of QOL change after treatment. A one-way analysis of variance was used to determine which variables were associated with trajectory membership. A multinomial logistic regression was performed to identify factors associated with trajectory group membership. Results: We analyzed 124 patients (mean age: 48.75 years). Latent class analysis of the QOL identified three trajectory groups: the low QOL group (n = 27; 21.1%), moderate QOL group (n = 57; 45.3%), and high QOL group (n = 40; 33.6%). The low QOL group showed consistently low QOL after the end of primary treatment, and the moderate QOL group showed a slight decrease in QOL from T1 to T3, which returned to the T1 level at T4. The high QOL group maintained a consistently high QOL. By multinomial logistic regression, psychological symptoms (odds ratio [OR] 0.46, 95% confidence interval [CI] 0.22–0.99) predicted a moderate QOL, and both psychological symptoms (OR 0.19, 95% CI 0.07–0.51) and belonging support (OR 1.60, 95% CI 1.06–2.39) predicted a high QOL. Conclusion: Identifying high-risk groups for reduced QOL after the end of primary treatment is necessary. Moreover, psychosocial interventions should be provided to alleviate psychological symptoms and increase belonging support to enhance patients' QOL. Trial registration Not registered.

1 January 2020 in Journal of Breast Cancer
Verified
Journal Article
Open access
JHJimi Huh
Jimi Huh
BPBumhee Park
Bumhee Park
HLHeirim Lee
Heirim Lee
YAYoung-Sil An
Young-Sil An
YJYongsik Jung
Yongsik Jung
TKTae Hee Kim
Tae Hee Kim
Huh J, et al. J Breast Cancer. 2019 Nov;23:e8. https://doi.org/10.4048/jbc.2020.23.e8

1 January 2019 in Journal of Breast Cancer
Verified
Journal Article
Open access
PDF file
MJMing Jin
Ming Jin
JKJi Young Kim
Ji Young Kim
TKTae Hee Kim
Tae Hee Kim
DKDoo Kyung Kang
Doo Kyung Kang
SHSe Hwan Han
Se Hwan Han
YJYongsik Jung
Yongsik Jung
Jin M, et al. J Breast Cancer. 2019 Jul;22:e58. https://doi.org/10.4048/jbc.2019.22.e58

1 January 2022 in Journal of Breast Cancer
Verified
Journal Article
Open access
PDF file
JRJai Min Ryu
Jai Min Ryu
HCHee Jun Choi
Hee Jun Choi
EPEunhwa Park
Eunhwa Park
JKJi Young Kim
Ji Young Kim
YLYoung Joo Lee
Young Joo Lee
KSKorean Breast Cancer Society
Korean Breast Cancer Society
Ryu JM, et al. J Breast Cancer. 2022 Apr;25(2):94-105. https://doi.org/10.4048/jbc.2022.25.e17

1 January 2017 in Journal of Breast Cancer
Verified
Journal Article
Open access
PDF file
YAYoung-Sil An
Young-Sil An
YJYongsik Jung
Yongsik Jung
JKJi Young Kim
Ji Young Kim
SHSehwan Han
Sehwan Han
DKDoo Kyoung Kang
Doo Kyoung Kang
TKTae Hee Kim
Tae Hee Kim
The aims of our study were to correlate the degree of metabolic activity in normal glandular tissue measured on 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) with qualitative background parenchymal enhancement (BPE) grades on magnetic resonance imaging (MRI), and to investigate the change in standardized uptake value (SUV) according to the patients' menstrual cycles. From January 2013 to December 2015, 298 consecutive premenopausal patients with breast cancer who underwent both breast MRI and 18F-FDG PET/CT were identified. BPE was evaluated in the contralateral breast of cancer patients and categorized as minimal, mild, moderate, or marked based on Breast Imaging Reporting and Data System criteria. We analyzed the correlation between BPE and maximum SUV (SUVmax) and mean SUV (SUVmean) values. We also analyzed the metabolic activity of normal glandular tissue according to the patients' menstrual cycles. The mean SUVmax and SUVmean values differed significantly according to BPE grade (p<0001), with the lowest values occurring in the minimal group and the highest values occurring in the marked group. Spearman's correlation coefficients revealed moderate correlations between BPE grade and SUVmax (r=0.472, p<0.001) and BPE and SUVmean (r=0.498, p<0.001). The mean SUVmax and SUVmean values differed significantly according to the patients' menstrual cycles, with the highest values in the 3rd week and the lowest value in the 2nd week. Of 29 patients with low metabolic parenchyma (high BPE but low SUVmean values), 17 (58.6%) were in the 4th week of their menstrual cycle. The metabolic activity of normal breast parenchyma, which is highest in the 3rd week and lowest in the 2nd week of the menstrual cycle, correlates moderately with BPE on MRI. Metabolic activity tends to be lower than blood flow and vessel permeability in the 4th week of the menstrual cycle.

1 January 2020 in Journal of Breast Cancer
Verified
Journal Article
Open access
JKJi Young Kim
Ji Young Kim
KYKyung Min Yang
Kyung Min Yang
JYJi Hyun Youn
Ji Hyun Youn
HPHeejun Park
Heejun Park
HHHyung Min Hahn
Hyung Min Hahn
ILIl Jae Lee
Il Jae Lee
Kim JY, et al. J Breast Cancer. 2019 Nov;23:e64. https://doi.org/10.4048/jbc.2020.23.e64